An Exceedingly Rare Case Of Liraglutide-Induced Liver Injury
CASE REPORTS IN GASTROINTESTINAL MEDICINE(2021)
摘要
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
更多查看译文
关键词
liver injury,liraglutide-induced
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要